Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistZhejiang Easyclean Daily Chemical Co., Ltd, a Chinese manufacturer of over-the-counter drug products, failed to conduct adequate finished product testing to verify the identity and strength of active ingredients prior to release to the U.S. market, in violation of Current Good Manufacturing Practice (CGMP) regulations. The company's inability to provide appropriate laboratory testing for batch conformance to final specifications meant its drug products were adulterated and lacked scientific evidence of proper ingredient content. This compliance failure was identified through FDA's review of records submitted in response to a March 2024 inspection request under section 704(a)(4) of the Federal Food, Drug, and Cosmetic Act.